Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Su Wang, MD MPH (she/her/hers)

Medical Director. Viral Hepatitis Programs | Senior Advisor, Global Health
Saint Barnabas Medical Center| Hepatitis B Foundation
Florham Park, NJ, United States

Su Wang, MD, MPH is an internal medicine physician and the Medical Director of Viral Hepatitis Programs & the Center for Asian Health at Cooperman Barnabas Medical Center in New Jersey, USA.

Dr. Wang has served as primary investigator for a number of viral hepatitis screening and linkage-to-care grants sponsored by the US CDC and other funders. She has led primary care based hepatitis B and C programs, community outreach efforts, patient based advocacy, and community based research initiatives. Dr. Wang has served on a number of WHO guideline development committees including ”Prevention of mother-to-child transmission of hepatitis B virus: Guidelines on antiviral prophylaxis in pregnancy”, the “Interim guidance for country validation of viral hepatitis elimination" and the guidelines development group for the 2023 WHO update on Hepatitis B Guidelines.

She is the Senior Advisor for Global Health for the Hepatitis B Foundaiton. She is living with hepatitis B and from 2020-2022 was President of the World Hepatitis Alliance (WHA), a non governmental organization whose mission is to harness the power of people living with viral hepatitis to achieve its elimination. Her work with WHA has focused on amplifying the voice of people living with hepatitis and affected communities to achieve health equity on the road to hepatitis elimination.

She received her medical degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine/ Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the Centers for Disease Control and Prevention (CDC) at the US Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.

Disclosure(s): Gilead Sciences: Grant/Research Support (Ongoing)

Presentation(s):